02 Jun 2025|Noida | Amity University, Noida
Faculty Development Programme on “Medical Device, Pharmacovigilance & Clinical Trial Regulations for Pharma & Biotech Industries”, held at Amity
Amity Institute of Pharmacy and Amity Institute of Biotechnology, in association with Tenet Health Edutech Pvt. Ltd. (Cliniminds) and Amity Academic Staff College, organized One Week Faculty Development Programme (FDP) on the theme “Medical Device, Pharmacovigilance & Clinical Trial Regulations for Pharma & Biotech Industries”, from 02 June to 06 June 2025.
Inaugurating the Programme, Chief Guest, Dr. Aseem Sahu, Deputy Drugs Controller, India, CDSCO, deliberated upon “Medical Device Regulations in India” and highlighted India’s regulatory evolution, including the Drugs and Cosmetics Act, 1940, and Medical Device Rules, 2017, focusing on risk-based classification, global harmonization, and patient-centric regulation.
Dr. W. Selvamurthy, President- ASTIF, delivered an inspiring address, emphasizing regulatory awareness, innovation, and the importance of ethical standards in clinical research. He lauded Dr. Aseem Sahu for his patient-centric regulatory approach and connected the FDP’s mission with national goals like Viksit Bharat @2047, Atma Nirbhar Bharat, and Mission Swasth Bharat. He urged the faculty members to transcend institutional boundaries and work collaboratively toward a unified vision of scientific progress.
Addressing the audience, Prof. (Dr.) Chanderdeep Tandon, Additional Pro Vice Chancellor, AUUP, appreciated the organizing team’s efforts and extended his best wishes for the successful execution of the week-long programme.
Prof. (Dr.) Bhudev C. Das, Dean, Faculty of Health & Allied Sciences, AUUP, acknowledged the visionary leadership of the Hon’ble Founder and Vice Chancellor of Amity University and underlined the FDP’s purpose of enhancing awareness around evolving regulatory systems. He encouraged faculty to utilize this platform for research collaboration, compliance-oriented learning, and academic excellence.
The Technical Sessions began with the session of Dr. Vivek Ahuja, Senior Vice President, EVERSANA, who spoke on “To AI or NOT to AI in Pharmacovigilance,” emphasizing upon the vital role of human oversight alongside AI. Mr. Goutam Bhattacharya, CEO, LSSSDC, deliberated upon the topic “Shaping India’s Life Sciences Future,” and highlighted the importance of skill development, innovation, and the transition toward New Chemical Entities through Centres of Excellence and academia-industry collaboration.
The sessions featured industry experts including Mr. Gurpreet Singh, Vice President, Managing Director Integrated Safety, IQVIA, Dr. Poornima Trivedi, Manager – Quality & Regulatory Affairs, Fresenius Medical Care India, and Mr. Kamal Shahani, Managing Director, Cliniminds, who shared valuable insights on global drug development trends, advanced drug safety and pharmacovigilance, and emerging opportunities in the life sciences sector from their respective areas of expertise. The first day of the FDP concluded with an interactive session, bringing together approximately 70 delegates from various universities across India to foster collaboration and knowledge sharing.